Mary Scoviak, Managing Editor

and joined the MJH Life Sciences team in April 2021. She graduated from Kent State University in 2018 with a bachelor's degree in journalism and a minor in sociology. Linda used to work as a creative writer for 

 and was a technical writer/regulatory specialist/purchasing agent at GM Industrial before coming on to the team. She enjoys reading, traveling, and learning new perspectives. You can reach her at 

Podcasts

This episode of The Cutaneous Connection podcast, explores hair loss and hair treatment of patients with textured or tightly coiled hair. Candrice Heath, MD, FAAP, FAAD a dermatologist and assistant professor of dermatology at the Lewis Katz School of Medicine at Temple University, explains her experience and highlights how all dermatologists can improve their treatment plans. 

The Cutaneous Connection: Treating and Relating to Patients of All Hair Types

Articles

Skin cancer dermoscopy is getting a hightech overhaul as the scope of innovation broadens from a singular focus on the stand-alone product to the development of a comprehensive medical, patient care, and workflow management platform.

Digital Device Aids Skin Cancer Diagnostics

Skin sensitivity will be a factor in vehicles for new treatments.

Impact of Itch Sparks New Pipeline Direction

Long underserved by a narrow armamentarium, patients with pigmentary disorders could soon see a new wave of oral and topical solutions to treat even the most challenging cases. 

New Drugs, Devices Could Revolutionize Pigmentary Treatment 

The recent approval of a topical androgen receptor inhibitor fills a longtime need in acne treatment. 

Clascoterone Cream First Topical to Target Androgen Receptors

The past year gave dermatologists ample cause for both celebration and frustration as they looked forward to new drugs, devices, and technology
to optimize patient care. Here, Dermatology Times® editorial advisory board members weigh in on the good, bad, and still-TBD changes that shaped the specialty during 2021.

2021's Breakthroughs & Disappointments

Factors ranging from demographics to the COVID-19 pandemic are shifting the landscape of occupational dermatoses.

Work Smarter to Manage Occupational Dermatoses

Videos

In this video interview, James Q Del Rosso, DO, tackles the clinical impact of JAK Inhibitors and how to deal with patient concern. 

Clinical Implications of JAK Inhibitors

In this exclusive video interview, James Q Del Rosso, DO, gets into the details of JAK inhibitors, explaining how they work and cutting through the headlines around the treatments. 

JAK Inhibitors: Drilling Down the Details

In a video for Dermatology Times®, Mark Lebwohl, MD, details how to match patients with the right psoriasis treatment for their specific needs. 